Informatics Science Industry Insights

A person using a holographic touchscreen, displaying a flowchart and some binary code.

Industry Insight

AI Brings the Next Generation of the Electronic Lab Notebook

Discover how an AI-enabled electronic lab notebook can help researchers to optimize experiments, collaborate and work smarter in R&D labs.

Illustration of synthetic mRNA structure for cell-free DNA synthesis.

Industry Insight

Unlocking mRNA Therapeutics: Cell-Free DNA Synthesis Is Powering the AI Era of Genetic Medicine

Discover how cell-free DNA synthesis can accelerate mRNA vaccines and therapies, enhancing production efficiency and lowering contamination risks.

A scientist in a lab coat presenting a hologram of a pill that symbolizes AI in drug toxicity research.

Industry Insight

Old Drug, New Tricks: AI Helps Rescue Failed Medicines

Learn how Ignota Labs is addressing drug toxicity challenges through AI, aiming to revive effective yet shelved drugs.

A scientist holding a tablet with a hologram floating above it, that contains a diagram of the human body and a large icon reading "AI".

Industry Insight

The Bottleneck in Biotech Isn’t AI Technology — It’s Trust

Trust is often a major barrier to companies integrating AI tools. Learn how better data governance can improve confidence.

Mark Fish presenting his keynote talk, in front of a large screen.

Industry Insight

Building the Automated Digital Lab of the Future

Discover the power of the automated digital lab for furthering scientific research and the importance of open collaboration.

Industry Insight

Mapping Microglia To Unlock New Paths in Neuroscience

Dr. Najat Khan of Recursion shared insights into the creation of the Microglia Map and what it could mean for future drug discovery.

Digital 3D model of a protein structure representing data-driven proteomics research.

Industry Insight

Beyond Mutations: Inside Immuto’s Quest To Decode Disease Structure

Immuto Scientific’s structural surfaceomics platform reveals how wild-type proteins adopt disease-specific shapes that drive pathology. Immuto identifies previously invisible drug targets and designs conformation-selective therapies.

Blue drug capsule with lower half made from computer network and the upper half containing small human brains.

Industry Insight

AI-Powered Platforms Are Making Complex Data Usable for Drug Discovery

In this interview, we explore how Sonrai is advancing reproducible science, enabling cross-disciplinary collaboration and shaping the future of AI-powered drug discovery.